End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.58 CNY | -0.92% | +2.26% | -18.29% |
04-29 | Healthcare Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-20 | Biggest cyberattacks in US healthcare sector | RE |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company sustains low margins.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Home Furnishings
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.29% | 678M | - | ||
+6.79% | 9.45B | B | ||
+2.00% | 4.02B | C- | ||
+16.49% | 2.45B | C | ||
+16.75% | 1.97B | - | ||
-3.95% | 1.51B | B- | ||
+45.93% | 1.29B | - | ||
-26.45% | 1.19B | C+ | ||
+14.46% | 1.02B | - | ||
+10.84% | 935M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603313 Stock
- Ratings Healthcare Co.,Ltd.